← back to database
TCGX is a science-driven investment firm focused on innovative biotechnology companies developing transformative medicines. Its closed-end fund structure supports private and public companies across the drug-development lifecycle.
Stage focus
Lead / follow
Check size
Ownership target
Specialization
Generalist / Specialist
Specialist
Latest fund size
$1.3B (Fund III)
Latest fund vintage
2025
Investing team
Bill ZhangAnalyst
Cariad ChesterManaging Partner
Chen YuManaging Partner
George FengAssociate
Giuliano MarosticaManaging Partner
Haithem LaaribiAssociate
Michael AlbertAssociate
Suan TuangAssociate